Maria del Pilar de la Huerta Martinez is a businessperson who has been the head of 6 different companies. Currently, she is Chief Financial Officer at Biofrontera AG.
She is also on the board of Epidesease SL and 4basebio Plc.
In her past career she occupied the position of Member-Supervisory Board at 2invest AG, Chief Executive Officer at Genetrix SL, Chief Executive Officer & Director at Biotechnology Assets SA and Chief Executive Officer & Director at Antibióticos de León SLU (a subsidiary of Biotechnology Assets SA), Chief Executive Officer & Director at Noscira SA, Chief Executive Officer at Araclon Biotech SL and Director-Business Development at Zeltia SA.
Ms. De la Huerta Martinez received an undergraduate degree from Universidad Complutense de Madrid.